Showing results (31-40 of 154) with videos related to
Sort By:
Pageof 16
Pharmacogenomics|April 23, 2004
Pharmacogenomics of the OATP and OAT familiesCatia Marzolini, Rommel G Tirona, Richard B KimExpert Opinion on Drug Metabolism & Toxicology|October 16, 2024
Drug-drug interactions potential with the HIV-1 capsid inhibitor lenacapavirCatia Marzolini, Sara Gibbons, Daniel Seddon, et al.The Journal of Antimicrobial Chemotherapy|June 3, 2017
Darunavir concentrations in CSF of HIV-infected individuals when boosted with cobicistat versus ritonavirHanni Bartels, Laurent Decosterd, Manuel Battegay, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 7, 2009
Drug-drug interaction in a kidney transplant recipient receiving HIV salvage therapy and tacrolimusDominik Mertz, Manuel Battegay, Catia Marzolini, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2023
Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort DataMattia Berton, Sara Bettonte, Felix Stader, et al.Clinical Pharmacokinetics|August 8, 2019
Clinical Pharmacodynamics, Pharmacokinetics, and Drug Interaction Profile of DoravirineAlison Boyle, Catherine E Moss, Catia Marzolini, et al.Clinical Pharmacology and Therapeutics|January 30, 2004
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevanceCatia Marzolini, Erik Paus, Thierry Buclin, et al.International Journal of STD & AIDS|May 10, 2014
Etravirine: a good option for concomitant use with chemotherapy for Hodgkin's lymphomaMario Kurz, Marcel Stoeckle, Fatime Krasniqi, et al.Swiss Medical Weekly|January 24, 2014
Gastrointestinal bleeding associated with rivaroxaban administration in a treated patient infected with human immunodeficiency virusBotond Lakatos, Marcel Stoeckle, Luigia Elzi, et al.Expert Opinion on Drug Metabolism & Toxicology|April 16, 2015
Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapiesDarren Michael Moss, Catia Marzolini, Rajith K R Rajoli, et al.Pageof 16